Live feed
·
INSIDERFiling
CRISPR Therapeutics AG logo

Chief Financial Officer Prasad Raju sold $476,278 worth of shares (9,869 units at $48.26), gifted 750 shares and converted options into 16,875 shares, increasing direct ownership by 92% to 13,023 units (SEC Form 4)